Clinico-epidemiological profile and outcomes of adults with COVID-19: A hospital-based retrospective study in Kerala, India.
COVID-19
Clinical
India
Kerala
coronavirus
epidemiological
hospitalized
symptoms
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
21
11
2021
revised:
03
02
2022
accepted:
07
02
2022
entrez:
19
9
2022
pubmed:
20
9
2022
medline:
20
9
2022
Statut:
ppublish
Résumé
The clinical and epidemiological presentations of patients with coronavirus disease 2019 (COVID-19) in India is still not well explored. We studied the epidemiological and clinical profile and outcomes of COVID-19 patients admitted to a tertiary care private hospital in Kerala, India. In this retrospective study, we analyzed data of 476 adult (≥18 years) COVID-19 patients admitted to a tertiary care hospital in Kerala from September 1, 2020 to March 31, 2021. The patients were categorized into mild, moderate, and severe cases and followed till discharge or death. Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 23.0 with a significance set at The median age was 57 years (56% men). Mild, moderate, and severe cases accounted for 17%, 65%, and 18%, respectively. Around 75% had at least one comorbidity, and 51% had multiple comorbidities. The most common comorbidities were diabetes (45%), hypertension (44%), dyslipidemia (15%), and cardiac problems (12%). The elevated D-dimer values among patients in different categories were significantly different, with 74% in severe, 46% in moderate, and 19% in mild category patients. Serum ferritin, C-reactive protein, lactic acid dehydrogenase, and neutrophil to lymphocyte ratio values were significantly higher for severely ill patients. Thirty deaths (67% men) occurred during the study period, with a case fatality rate of 6.3%. Mortality mainly happened in the older age group (80%) and those with multimorbidity (90%). Age and multimorbidity are the major contributing factors for death in hospitalized COVID-19 patients. Generalization of the findings necessitates well-designed large-scale studies.
Identifiants
pubmed: 36119227
doi: 10.4103/jfmpc.jfmpc_2273_21
pii: JFMPC-11-3000
pmc: PMC9480700
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3000-3005Informations de copyright
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100971
pubmed: 35075439
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Acta Anaesthesiol Scand. 2021 Mar;65(3):351-359
pubmed: 33128800
Hum Resour Health. 2021 Mar 22;19(1):39
pubmed: 33752675
J Family Med Prim Care. 2020 Dec 31;9(12):6261-6266
pubmed: 33681074
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
BMC Infect Dis. 2020 Jun 18;20(1):427
pubmed: 32552751
Mater Today Proc. 2021 Apr 13;:
pubmed: 33868964
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Cureus. 2020 Mar 21;12(3):e7355
pubmed: 32328367
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759
pubmed: 32663409
Indian J Public Health. 2020 Jun;64(Supplement):S183-S187
pubmed: 32496252
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Indian Pediatr. 2020 Oct 15;57(10):914-917
pubmed: 32729850
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
Indian J Med Res. 2021 Jan & Feb;153(1 & 2):115-125
pubmed: 33818468